MEMORIAL SLOAN-KETTERING CANCER CENTER

Serial Number 75340618
Registration 2315264
800

Registration Progress

Application Filed
Aug 13, 1997
Under Examination
Approved for Publication
Oct 15, 1999
Published for Opposition
Nov 16, 1999
Registered
Feb 8, 2000

Trademark Image

MEMORIAL SLOAN-KETTERING CANCER CENTER

Basic Information

Serial Number
75340618
Registration Number
2315264
Filing Date
August 13, 1997
Registration Date
February 8, 2000
Published for Opposition
November 16, 1999
Renewal Date
February 8, 2020
Drawing Code
1000

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 3, 2020
Registration
Registered
Classes
042

Rights Holder

Memorial Sloan-Kettering Cancer Center

03
Address
1275 York Avenue, Mailbox 524
New York, NY 10065

Ownership History

Memorial Sloan-Kettering Cancer Center

Original Applicant
03
New York, NY

Memorial Sloan-Kettering Cancer Center

Owner at Publication
03
New York, NY

Memorial Sloan-Kettering Cancer Center

Original Registrant
03
New York, NY

Legal Representation

Attorney
Karol Kepchar

USPTO Deadlines

Next Deadline
1509 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20000208)
Due Date
February 08, 2030
Grace Period Ends
August 08, 2030

Application History

29 events
Date Code Type Description Documents
Apr 3, 2020 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Apr 3, 2020 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Apr 3, 2020 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Apr 3, 2020 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Mar 27, 2020 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Loading...
Mar 27, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 31, 2020 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Feb 8, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 26, 2009 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Jun 26, 2009 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
May 27, 2009 PLGL A ASSIGNED TO PARALEGAL Loading...
May 22, 2009 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Apr 13, 2009 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 13, 2009 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 23, 2006 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
May 16, 2006 CFIT O CASE FILE IN TICRS Loading...
May 9, 2006 PLGL A ASSIGNED TO PARALEGAL Loading...
Feb 7, 2006 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Feb 7, 2006 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Feb 8, 2000 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 16, 1999 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 15, 1999 NPUB O NOTICE OF PUBLICATION Loading...
Jun 21, 1999 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 1, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 8, 1999 PETG O PETITION TO REVIVE-GRANTED Loading...
Feb 1, 1999 PETR I PETITION TO REVIVE-RECEIVED Loading...
May 31, 1999 ZZZY Z PREVIOUS ACTION COUNT WITHDRAWN Loading...
Apr 3, 1998 CNRT F NON-FINAL ACTION MAILED Loading...
Mar 25, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 042
medical services, hospital services, pharmacy services, and medical research services, namely, patient treatment and care; pharmaceutical prescription, formulation, and dispensing services; research in the biomedical sciences including molecular biology, cell biology, genetics, and immunology; and providing medical services in the nature of patient consultations, medical research, and medical information via telemedicine and video/teleconferencing
First Use Anywhere: 18841200
First Use in Commerce: 18841200

Additional Information

Pseudo Mark
MEMORIAL SLOAN KETTERING CANCER CENTER

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MEMORIAL" and "CANCER CENTER"